Olodaterol Oral Inhalation

316 interactions 36 cited references

Also sold as: Striverdi Striverdi® Respimat®

About Olodaterol Oral Inhalation

Olodaterol oral inhalation is used to control wheezing, shortness of breath, coughing, and chest tightness caused by chronic obstructive pulmonary disease (COPD; a group of diseases that affect the lungs and airways, which includes chronic bronchitis and emphysema). Olodaterol oral inhalation is in a class of medicatio… Read the full Olodaterol Oral Inhalation drug information page →

Medically reviewed by Dr. Brian Staiger, PharmD, BCPS · Updated Aug 9, 2026 · Editorial policy · Data sources

Sources: FDA prescribing information (Structured Product Labeling), the published literature cited in each entry, DDInter 2.0 (a major open-access drug-interaction database), and legacy DrugBank interaction data distributed by the NIH's RxNav service (decommissioned in 2024) — analyzed and reviewed by our pharmacist team. How we build this library →

Most serious with: Levoketoconazole Mesoridazine Pimozide Piperaquine Saquinavir Sparfloxacin

12 Contraindicated 247 Major 57 Moderate

All (316) Contraindicated (12) Major (247) Moderate (57)

Major

Olodaterol Oral Inhalation Nafarelin An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Oral Inhalation Nebivolol Bystolic Reduced olodaterol exposure and reduced beta-adrenergic blockers exposure Details Olodaterol Oral Inhalation Nelfinavir Viracept An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Oral Inhalation Nilotinib An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Oral Inhalation Norepinephrine An increased risk of clinically significant cardiovascular effects and fatalities and an increased/potentiated sympathetic effects... Details Olodaterol Oral Inhalation Norfloxacin An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Oral Inhalation Nortriptyline Potentiated cardiovascular effects Details Olodaterol Oral Inhalation Octreotide Bynfezia An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Oral Inhalation Ofloxacin Floxin® An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Oral Inhalation Olanzapine An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Oral Inhalation Ondansetron An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Oral Inhalation Opipramol Potentiated cardiovascular effects Details Olodaterol Oral Inhalation Osilodrostat Isturisa An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Oral Inhalation Osimertinib Tagrisso An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Oral Inhalation Oxaliplatin An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Oral Inhalation Oxprenolol Reduced olodaterol exposure and reduced beta-adrenergic blockers exposure Details Olodaterol Oral Inhalation Oxymetazoline Afrin An increased risk of clinically significant cardiovascular effects and fatalities and an increased/potentiated sympathetic effects... Details Olodaterol Oral Inhalation Ozanimod Potentiated cardiovascular effects Details Olodaterol Oral Inhalation Paliperidone Erzofri An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Oral Inhalation Panobinostat Farydak An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Oral Inhalation Papaverine Pavacot® An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Oral Inhalation Paroxetine Paxil An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Oral Inhalation Pasireotide Signifor An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Oral Inhalation Pazopanib Votrient An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Oral Inhalation Penbutolol Levatol® Reduced olodaterol exposure and reduced beta-adrenergic blockers exposure Details Olodaterol Oral Inhalation Pentamidine NebuPent An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Oral Inhalation Perphenazine An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Oral Inhalation Phenelzine Nardil Potentiated cardiovascular effects Details Olodaterol Oral Inhalation Phenylephrine Biorphen An increased risk of clinically significant cardiovascular effects and fatalities and an increased/potentiated sympathetic effects... Details Olodaterol Oral Inhalation Pimavanserin Nuplazid An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Oral Inhalation Pindolol Visken® Reduced olodaterol exposure and reduced beta-adrenergic blockers exposure Details Olodaterol Oral Inhalation Pipamperone An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Oral Inhalation Pitolisant Wakix An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Oral Inhalation Ponesimod Ponvory An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Oral Inhalation Posaconazole Noxafil An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Oral Inhalation Probucol An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Oral Inhalation Procainamide Procan® An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Oral Inhalation Procarbazine Potentiated cardiovascular effects Details Olodaterol Oral Inhalation Prochlorperazine An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Oral Inhalation Promethazine Phenadoz An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details

Check another drug

Still have questions about this combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

Ask the pharmacist

Educational information only, not medical advice. Always confirm interactions with your pharmacist or prescriber before making any change to your medications.